50 participants
Bevacizumab and Erlotinib in the Treatment of Patients With Carcinoma of Unknown Primary Site
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2010-09-17
- Start Date:
- 2004-04-30
- Completion:
- 2005-09-30
Conditions
- Neoplasms, Unknown Primary
Interventions
- DRUG
No Results Yet